#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Loss of consciousness Uterine leiomyosarcoma Hepatoblastoma Graft versus host disease Dementia with Lewy bodies Carcinoid tumour Chronic myeloid leukaemia (in remission) Small intestine adenocarcinoma Desmoid tumour Turner's syndrome Hypertriglyceridaemia Immunodeficiency Epstein-Barr virus infection Prader-Willi syndrome Interstitial lung disease More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Trials in Disease Basal cell naevus syndrome – Basic Information Waldenstrom’s macroglobulinaemia Systemic sclerosis pulmonary – Life with Disease Angiosarcoma recurrent – Trials in Disease X-linked lymphoproliferative syndrome – Trials in Disease Lysosomal storage disorder – Treatment Primary immunodeficiency syndrome – Trials in Disease Focal segmental glomerulosclerosis – Basic Information Encephalitis autoimmune – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Roxithromycin Fluorouracil Dobutamine Canakinumab Lenalidomide Tetrahydrouridine Cldn6 Car-T(A) Ustekinumab Erythromycin Misoprostol Imiquimod Kpl-404 Gs-1427 Umeclidinium Xaluritamig ORG-129 64Cu-Dota-Ae105 Cobamamide Ima203Cd8 Icosapent Ethyl More therapies…

    Learn about Your Condition

    Glomerulonephritis acute Transplant rejection Haemoglobinuria Neuromyopathy Bipolar I disorder Cardiac arrest Insulin resistance Coronary artery disease Thalassaemia beta Nephrogenic anaemia Oral neoplasm Leukocyte adhesion deficiency Epicondylitis Benign neoplasm of ureter Hepatotoxicity More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Propranolol for Reducing Anxiety in Patients with Pancreatic Cancer Before Surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    Investigated Drugs:
    • Propranolol
    • Placebo
    Denmark

  • Study on Omega-3 Fatty Acids for Reducing Organ Failure and Mortality in Patients with Severe Acute Pancreatitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatitis acute
    Investigated Drugs:
    • Glycerol
    • Highly Refined Fish Oil
    • Purified Egg Phospholipids
    Denmark The Netherlands

  • Study on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Exl01
    • Vancomycin
    France

  • Study of Oral Vancomycin for Adults and Young Adults with Primary Sclerosing Cholangitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Vancomycin
    Italy

  • Study Comparing Vedolizumab and Adalimumab for Crohn’s Disease Patients Who No Longer Respond to Adalimumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Adalimumab
    France

  • Study on MBK-01 and Drug Combination for Treating Patients with Recurrent Diverticulitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diverticulitis
    Investigated Drugs:
    • Amoxicillin
    • Allogeneic Faecal Microbiota, Pooled
    • Fosfomycin
    Spain
Previous Page
1 … 37 38 39 40 41 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!